ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmaceutical Grade Safinamide Mesylate Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-9I14311
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharmaceutical Grade Safinamide Mesylate Market Research Report 2023
BUY CHAPTERS

Global Pharmaceutical Grade Safinamide Mesylate Market Research Report 2025

Code: QYRE-Auto-9I14311
Report
May 2025
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
SOLARA ACTIVE PHARMA SCIENCES LTD
Biophore India Pharmaceuticals Pvt. Ltd.
Aurobindo Pharma Ltd.
OPTIMUS DRUGS PRIVATE LTD
MSN Life Sciences Private Ltd
Zhejiang Huahai Pharmaceutical Co., Ltd.
APICORE PHARMACEUTICALS PRIVATE LTD

Pharmaceutical Grade Safinamide Mesylate Market Size

The global market for Pharmaceutical Grade Safinamide Mesylate was valued at US$ 545 million in the year 2024 and is projected to reach a revised size of US$ 696 million by 2031, growing at a CAGR of 3.6% during the forecast period.

Pharmaceutical Grade Safinamide Mesylate Market

Pharmaceutical Grade Safinamide Mesylate Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Grade Safinamide Mesylate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Grade Safinamide Mesylate.
The Pharmaceutical Grade Safinamide Mesylate market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical Grade Safinamide Mesylate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Grade Safinamide Mesylate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pharmaceutical Grade Safinamide Mesylate Market Report

Report Metric Details
Report Name Pharmaceutical Grade Safinamide Mesylate Market
Accounted market size in year US$ 545 million
Forecasted market size in 2031 US$ 696 million
CAGR 3.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Purity≥99%
  • Purity<99%
Segment by Application
  • Tablets
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company SOLARA ACTIVE PHARMA SCIENCES LTD, BIOPHORE INDIA PHARMACEUTICALS PVT LTD, AUROBINDO PHARMA LTD, OPTIMUS DRUGS PRIVATE LTD, MSN LIFE SCIENCES PRIVATE LTD, APICORE PHARMACEUTICALS PRIVATE LTD, ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pharmaceutical Grade Safinamide Mesylate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Pharmaceutical Grade Safinamide Mesylate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Pharmaceutical Grade Safinamide Mesylate Market growing?

Ans: The Pharmaceutical Grade Safinamide Mesylate Market witnessing a CAGR of 3.6% during the forecast period 2025-2031.

What is the Pharmaceutical Grade Safinamide Mesylate Market size in 2031?

Ans: The Pharmaceutical Grade Safinamide Mesylate Market size in 2031 will be US$ 696 million.

Who are the main players in the Pharmaceutical Grade Safinamide Mesylate Market report?

Ans: The main players in the Pharmaceutical Grade Safinamide Mesylate Market are SOLARA ACTIVE PHARMA SCIENCES LTD, BIOPHORE INDIA PHARMACEUTICALS PVT LTD, AUROBINDO PHARMA LTD, OPTIMUS DRUGS PRIVATE LTD, MSN LIFE SCIENCES PRIVATE LTD, APICORE PHARMACEUTICALS PRIVATE LTD, ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD

What are the Application segmentation covered in the Pharmaceutical Grade Safinamide Mesylate Market report?

Ans: The Applications covered in the Pharmaceutical Grade Safinamide Mesylate Market report are Tablets, Others

What are the Type segmentation covered in the Pharmaceutical Grade Safinamide Mesylate Market report?

Ans: The Types covered in the Pharmaceutical Grade Safinamide Mesylate Market report are Purity≥99%, Purity<99%

Recommended Reports

Pharmaceutical Grade APIs

Active Pharmaceutical Ingredients

Specialty Pharmaceutical Products

1 Pharmaceutical Grade Safinamide Mesylate Market Overview
1.1 Product Definition
1.2 Pharmaceutical Grade Safinamide Mesylate by Type
1.2.1 Global Pharmaceutical Grade Safinamide Mesylate Market Value Comparison by Type (2024 VS 2031)
1.2.2 Purity≥99%
1.2.3 Purity<99%
1.3 Pharmaceutical Grade Safinamide Mesylate by Application
1.3.1 Global Pharmaceutical Grade Safinamide Mesylate Market Value by Application (2024 VS 2031)
1.3.2 Tablets
1.3.3 Others
1.4 Global Pharmaceutical Grade Safinamide Mesylate Market Size Estimates and Forecasts
1.4.1 Global Pharmaceutical Grade Safinamide Mesylate Revenue 2020-2031
1.4.2 Global Pharmaceutical Grade Safinamide Mesylate Sales 2020-2031
1.4.3 Global Pharmaceutical Grade Safinamide Mesylate Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pharmaceutical Grade Safinamide Mesylate Market Competition by Manufacturers
2.1 Global Pharmaceutical Grade Safinamide Mesylate Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pharmaceutical Grade Safinamide Mesylate Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pharmaceutical Grade Safinamide Mesylate Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pharmaceutical Grade Safinamide Mesylate, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pharmaceutical Grade Safinamide Mesylate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pharmaceutical Grade Safinamide Mesylate, Product Type & Application
2.7 Global Key Manufacturers of Pharmaceutical Grade Safinamide Mesylate, Date of Enter into This Industry
2.8 Global Pharmaceutical Grade Safinamide Mesylate Market Competitive Situation and Trends
2.8.1 Global Pharmaceutical Grade Safinamide Mesylate Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pharmaceutical Grade Safinamide Mesylate Players Market Share by Revenue
2.8.3 Global Pharmaceutical Grade Safinamide Mesylate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pharmaceutical Grade Safinamide Mesylate Market Scenario by Region
3.1 Global Pharmaceutical Grade Safinamide Mesylate Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pharmaceutical Grade Safinamide Mesylate Sales by Region: 2020-2031
3.2.1 Global Pharmaceutical Grade Safinamide Mesylate Sales by Region: 2020-2025
3.2.2 Global Pharmaceutical Grade Safinamide Mesylate Sales by Region: 2026-2031
3.3 Global Pharmaceutical Grade Safinamide Mesylate Revenue by Region: 2020-2031
3.3.1 Global Pharmaceutical Grade Safinamide Mesylate Revenue by Region: 2020-2025
3.3.2 Global Pharmaceutical Grade Safinamide Mesylate Revenue by Region: 2026-2031
3.4 North America Pharmaceutical Grade Safinamide Mesylate Market Facts & Figures by Country
3.4.1 North America Pharmaceutical Grade Safinamide Mesylate Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pharmaceutical Grade Safinamide Mesylate Sales by Country (2020-2031)
3.4.3 North America Pharmaceutical Grade Safinamide Mesylate Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pharmaceutical Grade Safinamide Mesylate Market Facts & Figures by Country
3.5.1 Europe Pharmaceutical Grade Safinamide Mesylate Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pharmaceutical Grade Safinamide Mesylate Sales by Country (2020-2031)
3.5.3 Europe Pharmaceutical Grade Safinamide Mesylate Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pharmaceutical Grade Safinamide Mesylate Market Facts & Figures by Region
3.6.1 Asia Pacific Pharmaceutical Grade Safinamide Mesylate Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pharmaceutical Grade Safinamide Mesylate Sales by Region (2020-2031)
3.6.3 Asia Pacific Pharmaceutical Grade Safinamide Mesylate Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pharmaceutical Grade Safinamide Mesylate Market Facts & Figures by Country
3.7.1 Latin America Pharmaceutical Grade Safinamide Mesylate Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pharmaceutical Grade Safinamide Mesylate Sales by Country (2020-2031)
3.7.3 Latin America Pharmaceutical Grade Safinamide Mesylate Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pharmaceutical Grade Safinamide Mesylate Market Facts & Figures by Country
3.8.1 Middle East and Africa Pharmaceutical Grade Safinamide Mesylate Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pharmaceutical Grade Safinamide Mesylate Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pharmaceutical Grade Safinamide Mesylate Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pharmaceutical Grade Safinamide Mesylate Sales by Type (2020-2031)
4.1.1 Global Pharmaceutical Grade Safinamide Mesylate Sales by Type (2020-2025)
4.1.2 Global Pharmaceutical Grade Safinamide Mesylate Sales by Type (2026-2031)
4.1.3 Global Pharmaceutical Grade Safinamide Mesylate Sales Market Share by Type (2020-2031)
4.2 Global Pharmaceutical Grade Safinamide Mesylate Revenue by Type (2020-2031)
4.2.1 Global Pharmaceutical Grade Safinamide Mesylate Revenue by Type (2020-2025)
4.2.2 Global Pharmaceutical Grade Safinamide Mesylate Revenue by Type (2026-2031)
4.2.3 Global Pharmaceutical Grade Safinamide Mesylate Revenue Market Share by Type (2020-2031)
4.3 Global Pharmaceutical Grade Safinamide Mesylate Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pharmaceutical Grade Safinamide Mesylate Sales by Application (2020-2031)
5.1.1 Global Pharmaceutical Grade Safinamide Mesylate Sales by Application (2020-2025)
5.1.2 Global Pharmaceutical Grade Safinamide Mesylate Sales by Application (2026-2031)
5.1.3 Global Pharmaceutical Grade Safinamide Mesylate Sales Market Share by Application (2020-2031)
5.2 Global Pharmaceutical Grade Safinamide Mesylate Revenue by Application (2020-2031)
5.2.1 Global Pharmaceutical Grade Safinamide Mesylate Revenue by Application (2020-2025)
5.2.2 Global Pharmaceutical Grade Safinamide Mesylate Revenue by Application (2026-2031)
5.2.3 Global Pharmaceutical Grade Safinamide Mesylate Revenue Market Share by Application (2020-2031)
5.3 Global Pharmaceutical Grade Safinamide Mesylate Price by Application (2020-2031)
6 Key Companies Profiled
6.1 SOLARA ACTIVE PHARMA SCIENCES LTD
6.1.1 SOLARA ACTIVE PHARMA SCIENCES LTD Company Information
6.1.2 SOLARA ACTIVE PHARMA SCIENCES LTD Description and Business Overview
6.1.3 SOLARA ACTIVE PHARMA SCIENCES LTD Pharmaceutical Grade Safinamide Mesylate Sales, Revenue and Gross Margin (2020-2025)
6.1.4 SOLARA ACTIVE PHARMA SCIENCES LTD Pharmaceutical Grade Safinamide Mesylate Product Portfolio
6.1.5 SOLARA ACTIVE PHARMA SCIENCES LTD Recent Developments/Updates
6.2 BIOPHORE INDIA PHARMACEUTICALS PVT LTD
6.2.1 BIOPHORE INDIA PHARMACEUTICALS PVT LTD Company Information
6.2.2 BIOPHORE INDIA PHARMACEUTICALS PVT LTD Description and Business Overview
6.2.3 BIOPHORE INDIA PHARMACEUTICALS PVT LTD Pharmaceutical Grade Safinamide Mesylate Sales, Revenue and Gross Margin (2020-2025)
6.2.4 BIOPHORE INDIA PHARMACEUTICALS PVT LTD Pharmaceutical Grade Safinamide Mesylate Product Portfolio
6.2.5 BIOPHORE INDIA PHARMACEUTICALS PVT LTD Recent Developments/Updates
6.3 AUROBINDO PHARMA LTD
6.3.1 AUROBINDO PHARMA LTD Company Information
6.3.2 AUROBINDO PHARMA LTD Description and Business Overview
6.3.3 AUROBINDO PHARMA LTD Pharmaceutical Grade Safinamide Mesylate Sales, Revenue and Gross Margin (2020-2025)
6.3.4 AUROBINDO PHARMA LTD Pharmaceutical Grade Safinamide Mesylate Product Portfolio
6.3.5 AUROBINDO PHARMA LTD Recent Developments/Updates
6.4 OPTIMUS DRUGS PRIVATE LTD
6.4.1 OPTIMUS DRUGS PRIVATE LTD Company Information
6.4.2 OPTIMUS DRUGS PRIVATE LTD Description and Business Overview
6.4.3 OPTIMUS DRUGS PRIVATE LTD Pharmaceutical Grade Safinamide Mesylate Sales, Revenue and Gross Margin (2020-2025)
6.4.4 OPTIMUS DRUGS PRIVATE LTD Pharmaceutical Grade Safinamide Mesylate Product Portfolio
6.4.5 OPTIMUS DRUGS PRIVATE LTD Recent Developments/Updates
6.5 MSN LIFE SCIENCES PRIVATE LTD
6.5.1 MSN LIFE SCIENCES PRIVATE LTD Company Information
6.5.2 MSN LIFE SCIENCES PRIVATE LTD Description and Business Overview
6.5.3 MSN LIFE SCIENCES PRIVATE LTD Pharmaceutical Grade Safinamide Mesylate Sales, Revenue and Gross Margin (2020-2025)
6.5.4 MSN LIFE SCIENCES PRIVATE LTD Pharmaceutical Grade Safinamide Mesylate Product Portfolio
6.5.5 MSN LIFE SCIENCES PRIVATE LTD Recent Developments/Updates
6.6 APICORE PHARMACEUTICALS PRIVATE LTD
6.6.1 APICORE PHARMACEUTICALS PRIVATE LTD Company Information
6.6.2 APICORE PHARMACEUTICALS PRIVATE LTD Description and Business Overview
6.6.3 APICORE PHARMACEUTICALS PRIVATE LTD Pharmaceutical Grade Safinamide Mesylate Sales, Revenue and Gross Margin (2020-2025)
6.6.4 APICORE PHARMACEUTICALS PRIVATE LTD Pharmaceutical Grade Safinamide Mesylate Product Portfolio
6.6.5 APICORE PHARMACEUTICALS PRIVATE LTD Recent Developments/Updates
6.7 ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD
6.7.1 ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Company Information
6.7.2 ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Description and Business Overview
6.7.3 ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Pharmaceutical Grade Safinamide Mesylate Sales, Revenue and Gross Margin (2020-2025)
6.7.4 ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Pharmaceutical Grade Safinamide Mesylate Product Portfolio
6.7.5 ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pharmaceutical Grade Safinamide Mesylate Industry Chain Analysis
7.2 Pharmaceutical Grade Safinamide Mesylate Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pharmaceutical Grade Safinamide Mesylate Production Mode & Process Analysis
7.4 Pharmaceutical Grade Safinamide Mesylate Sales and Marketing
7.4.1 Pharmaceutical Grade Safinamide Mesylate Sales Channels
7.4.2 Pharmaceutical Grade Safinamide Mesylate Distributors
7.5 Pharmaceutical Grade Safinamide Mesylate Customer Analysis
8 Pharmaceutical Grade Safinamide Mesylate Market Dynamics
8.1 Pharmaceutical Grade Safinamide Mesylate Industry Trends
8.2 Pharmaceutical Grade Safinamide Mesylate Market Drivers
8.3 Pharmaceutical Grade Safinamide Mesylate Market Challenges
8.4 Pharmaceutical Grade Safinamide Mesylate Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
SOLARA ACTIVE PHARMA SCIENCES LTD
Biophore India Pharmaceuticals Pvt. Ltd.
Aurobindo Pharma Ltd.
OPTIMUS DRUGS PRIVATE LTD
MSN Life Sciences Private Ltd
Zhejiang Huahai Pharmaceutical Co., Ltd.
APICORE PHARMACEUTICALS PRIVATE LTD
List of Tables
 Table 1. Global Pharmaceutical Grade Safinamide Mesylate Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Pharmaceutical Grade Safinamide Mesylate Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Pharmaceutical Grade Safinamide Mesylate Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Pharmaceutical Grade Safinamide Mesylate Sales (Tons) of Key Manufacturers (2020-2025)
 Table 5. Global Pharmaceutical Grade Safinamide Mesylate Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Pharmaceutical Grade Safinamide Mesylate Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Pharmaceutical Grade Safinamide Mesylate Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Pharmaceutical Grade Safinamide Mesylate Average Price (US$/Ton) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Pharmaceutical Grade Safinamide Mesylate, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Pharmaceutical Grade Safinamide Mesylate, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Pharmaceutical Grade Safinamide Mesylate, Product Type & Application
 Table 12. Global Key Manufacturers of Pharmaceutical Grade Safinamide Mesylate, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Pharmaceutical Grade Safinamide Mesylate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Grade Safinamide Mesylate as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pharmaceutical Grade Safinamide Mesylate Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Pharmaceutical Grade Safinamide Mesylate Sales by Region (2020-2025) & (Tons)
 Table 18. Global Pharmaceutical Grade Safinamide Mesylate Sales Market Share by Region (2020-2025)
 Table 19. Global Pharmaceutical Grade Safinamide Mesylate Sales by Region (2026-2031) & (Tons)
 Table 20. Global Pharmaceutical Grade Safinamide Mesylate Sales Market Share by Region (2026-2031)
 Table 21. Global Pharmaceutical Grade Safinamide Mesylate Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Pharmaceutical Grade Safinamide Mesylate Revenue Market Share by Region (2020-2025)
 Table 23. Global Pharmaceutical Grade Safinamide Mesylate Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Pharmaceutical Grade Safinamide Mesylate Revenue Market Share by Region (2026-2031)
 Table 25. North America Pharmaceutical Grade Safinamide Mesylate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Pharmaceutical Grade Safinamide Mesylate Sales by Country (2020-2025) & (Tons)
 Table 27. North America Pharmaceutical Grade Safinamide Mesylate Sales by Country (2026-2031) & (Tons)
 Table 28. North America Pharmaceutical Grade Safinamide Mesylate Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Pharmaceutical Grade Safinamide Mesylate Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Pharmaceutical Grade Safinamide Mesylate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Pharmaceutical Grade Safinamide Mesylate Sales by Country (2020-2025) & (Tons)
 Table 32. Europe Pharmaceutical Grade Safinamide Mesylate Sales by Country (2026-2031) & (Tons)
 Table 33. Europe Pharmaceutical Grade Safinamide Mesylate Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Pharmaceutical Grade Safinamide Mesylate Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Pharmaceutical Grade Safinamide Mesylate Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Pharmaceutical Grade Safinamide Mesylate Sales by Region (2020-2025) & (Tons)
 Table 37. Asia Pacific Pharmaceutical Grade Safinamide Mesylate Sales by Region (2026-2031) & (Tons)
 Table 38. Asia Pacific Pharmaceutical Grade Safinamide Mesylate Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Pharmaceutical Grade Safinamide Mesylate Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pharmaceutical Grade Safinamide Mesylate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Pharmaceutical Grade Safinamide Mesylate Sales by Country (2020-2025) & (Tons)
 Table 42. Latin America Pharmaceutical Grade Safinamide Mesylate Sales by Country (2026-2031) & (Tons)
 Table 43. Latin America Pharmaceutical Grade Safinamide Mesylate Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Pharmaceutical Grade Safinamide Mesylate Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Pharmaceutical Grade Safinamide Mesylate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Pharmaceutical Grade Safinamide Mesylate Sales by Country (2020-2025) & (Tons)
 Table 47. Middle East and Africa Pharmaceutical Grade Safinamide Mesylate Sales by Country (2026-2031) & (Tons)
 Table 48. Middle East and Africa Pharmaceutical Grade Safinamide Mesylate Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Pharmaceutical Grade Safinamide Mesylate Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Pharmaceutical Grade Safinamide Mesylate Sales (Tons) by Type (2020-2025)
 Table 51. Global Pharmaceutical Grade Safinamide Mesylate Sales (Tons) by Type (2026-2031)
 Table 52. Global Pharmaceutical Grade Safinamide Mesylate Sales Market Share by Type (2020-2025)
 Table 53. Global Pharmaceutical Grade Safinamide Mesylate Sales Market Share by Type (2026-2031)
 Table 54. Global Pharmaceutical Grade Safinamide Mesylate Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Pharmaceutical Grade Safinamide Mesylate Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Pharmaceutical Grade Safinamide Mesylate Revenue Market Share by Type (2020-2025)
 Table 57. Global Pharmaceutical Grade Safinamide Mesylate Revenue Market Share by Type (2026-2031)
 Table 58. Global Pharmaceutical Grade Safinamide Mesylate Price (US$/Ton) by Type (2020-2025)
 Table 59. Global Pharmaceutical Grade Safinamide Mesylate Price (US$/Ton) by Type (2026-2031)
 Table 60. Global Pharmaceutical Grade Safinamide Mesylate Sales (Tons) by Application (2020-2025)
 Table 61. Global Pharmaceutical Grade Safinamide Mesylate Sales (Tons) by Application (2026-2031)
 Table 62. Global Pharmaceutical Grade Safinamide Mesylate Sales Market Share by Application (2020-2025)
 Table 63. Global Pharmaceutical Grade Safinamide Mesylate Sales Market Share by Application (2026-2031)
 Table 64. Global Pharmaceutical Grade Safinamide Mesylate Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Pharmaceutical Grade Safinamide Mesylate Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Pharmaceutical Grade Safinamide Mesylate Revenue Market Share by Application (2020-2025)
 Table 67. Global Pharmaceutical Grade Safinamide Mesylate Revenue Market Share by Application (2026-2031)
 Table 68. Global Pharmaceutical Grade Safinamide Mesylate Price (US$/Ton) by Application (2020-2025)
 Table 69. Global Pharmaceutical Grade Safinamide Mesylate Price (US$/Ton) by Application (2026-2031)
 Table 70. SOLARA ACTIVE PHARMA SCIENCES LTD Company Information
 Table 71. SOLARA ACTIVE PHARMA SCIENCES LTD Description and Business Overview
 Table 72. SOLARA ACTIVE PHARMA SCIENCES LTD Pharmaceutical Grade Safinamide Mesylate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 73. SOLARA ACTIVE PHARMA SCIENCES LTD Pharmaceutical Grade Safinamide Mesylate Product
 Table 74. SOLARA ACTIVE PHARMA SCIENCES LTD Recent Developments/Updates
 Table 75. BIOPHORE INDIA PHARMACEUTICALS PVT LTD Company Information
 Table 76. BIOPHORE INDIA PHARMACEUTICALS PVT LTD Description and Business Overview
 Table 77. BIOPHORE INDIA PHARMACEUTICALS PVT LTD Pharmaceutical Grade Safinamide Mesylate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 78. BIOPHORE INDIA PHARMACEUTICALS PVT LTD Pharmaceutical Grade Safinamide Mesylate Product
 Table 79. BIOPHORE INDIA PHARMACEUTICALS PVT LTD Recent Developments/Updates
 Table 80. AUROBINDO PHARMA LTD Company Information
 Table 81. AUROBINDO PHARMA LTD Description and Business Overview
 Table 82. AUROBINDO PHARMA LTD Pharmaceutical Grade Safinamide Mesylate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 83. AUROBINDO PHARMA LTD Pharmaceutical Grade Safinamide Mesylate Product
 Table 84. AUROBINDO PHARMA LTD Recent Developments/Updates
 Table 85. OPTIMUS DRUGS PRIVATE LTD Company Information
 Table 86. OPTIMUS DRUGS PRIVATE LTD Description and Business Overview
 Table 87. OPTIMUS DRUGS PRIVATE LTD Pharmaceutical Grade Safinamide Mesylate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 88. OPTIMUS DRUGS PRIVATE LTD Pharmaceutical Grade Safinamide Mesylate Product
 Table 89. OPTIMUS DRUGS PRIVATE LTD Recent Developments/Updates
 Table 90. MSN LIFE SCIENCES PRIVATE LTD Company Information
 Table 91. MSN LIFE SCIENCES PRIVATE LTD Description and Business Overview
 Table 92. MSN LIFE SCIENCES PRIVATE LTD Pharmaceutical Grade Safinamide Mesylate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. MSN LIFE SCIENCES PRIVATE LTD Pharmaceutical Grade Safinamide Mesylate Product
 Table 94. MSN LIFE SCIENCES PRIVATE LTD Recent Developments/Updates
 Table 95. APICORE PHARMACEUTICALS PRIVATE LTD Company Information
 Table 96. APICORE PHARMACEUTICALS PRIVATE LTD Description and Business Overview
 Table 97. APICORE PHARMACEUTICALS PRIVATE LTD Pharmaceutical Grade Safinamide Mesylate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 98. APICORE PHARMACEUTICALS PRIVATE LTD Pharmaceutical Grade Safinamide Mesylate Product
 Table 99. APICORE PHARMACEUTICALS PRIVATE LTD Recent Developments/Updates
 Table 100. ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Company Information
 Table 101. ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Description and Business Overview
 Table 102. ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Pharmaceutical Grade Safinamide Mesylate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 103. ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Pharmaceutical Grade Safinamide Mesylate Product
 Table 104. ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Pharmaceutical Grade Safinamide Mesylate Distributors List
 Table 108. Pharmaceutical Grade Safinamide Mesylate Customers List
 Table 109. Pharmaceutical Grade Safinamide Mesylate Market Trends
 Table 110. Pharmaceutical Grade Safinamide Mesylate Market Drivers
 Table 111. Pharmaceutical Grade Safinamide Mesylate Market Challenges
 Table 112. Pharmaceutical Grade Safinamide Mesylate Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pharmaceutical Grade Safinamide Mesylate
 Figure 2. Global Pharmaceutical Grade Safinamide Mesylate Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pharmaceutical Grade Safinamide Mesylate Market Share by Type: 2024 & 2031
 Figure 4. Purity≥99% Product Picture
 Figure 5. Purity<99% Product Picture
 Figure 6. Global Pharmaceutical Grade Safinamide Mesylate Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Pharmaceutical Grade Safinamide Mesylate Market Share by Application: 2024 & 2031
 Figure 8. Tablets
 Figure 9. Others
 Figure 10. Global Pharmaceutical Grade Safinamide Mesylate Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Pharmaceutical Grade Safinamide Mesylate Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Pharmaceutical Grade Safinamide Mesylate Sales (2020-2031) & (Tons)
 Figure 13. Global Pharmaceutical Grade Safinamide Mesylate Average Price (US$/Ton) & (2020-2031)
 Figure 14. Pharmaceutical Grade Safinamide Mesylate Report Years Considered
 Figure 15. Pharmaceutical Grade Safinamide Mesylate Sales Share by Manufacturers in 2024
 Figure 16. Global Pharmaceutical Grade Safinamide Mesylate Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Pharmaceutical Grade Safinamide Mesylate Players: Market Share by Revenue in Pharmaceutical Grade Safinamide Mesylate in 2024
 Figure 18. Pharmaceutical Grade Safinamide Mesylate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Pharmaceutical Grade Safinamide Mesylate Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Pharmaceutical Grade Safinamide Mesylate Sales Market Share by Country (2020-2031)
 Figure 21. North America Pharmaceutical Grade Safinamide Mesylate Revenue Market Share by Country (2020-2031)
 Figure 22. United States Pharmaceutical Grade Safinamide Mesylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Pharmaceutical Grade Safinamide Mesylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Pharmaceutical Grade Safinamide Mesylate Sales Market Share by Country (2020-2031)
 Figure 25. Europe Pharmaceutical Grade Safinamide Mesylate Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Pharmaceutical Grade Safinamide Mesylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Pharmaceutical Grade Safinamide Mesylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Pharmaceutical Grade Safinamide Mesylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Pharmaceutical Grade Safinamide Mesylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Pharmaceutical Grade Safinamide Mesylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Pharmaceutical Grade Safinamide Mesylate Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Pharmaceutical Grade Safinamide Mesylate Revenue Market Share by Region (2020-2031)
 Figure 33. China Pharmaceutical Grade Safinamide Mesylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Pharmaceutical Grade Safinamide Mesylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Pharmaceutical Grade Safinamide Mesylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Pharmaceutical Grade Safinamide Mesylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Pharmaceutical Grade Safinamide Mesylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Pharmaceutical Grade Safinamide Mesylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Pharmaceutical Grade Safinamide Mesylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Pharmaceutical Grade Safinamide Mesylate Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Pharmaceutical Grade Safinamide Mesylate Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Pharmaceutical Grade Safinamide Mesylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Pharmaceutical Grade Safinamide Mesylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Pharmaceutical Grade Safinamide Mesylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Middle East and Africa Pharmaceutical Grade Safinamide Mesylate Sales Market Share by Country (2020-2031)
 Figure 46. Middle East and Africa Pharmaceutical Grade Safinamide Mesylate Revenue Market Share by Country (2020-2031)
 Figure 47. Turkey Pharmaceutical Grade Safinamide Mesylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Pharmaceutical Grade Safinamide Mesylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. UAE Pharmaceutical Grade Safinamide Mesylate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Global Sales Market Share of Pharmaceutical Grade Safinamide Mesylate by Type (2020-2031)
 Figure 51. Global Revenue Market Share of Pharmaceutical Grade Safinamide Mesylate by Type (2020-2031)
 Figure 52. Global Pharmaceutical Grade Safinamide Mesylate Price (US$/Ton) by Type (2020-2031)
 Figure 53. Global Sales Market Share of Pharmaceutical Grade Safinamide Mesylate by Application (2020-2031)
 Figure 54. Global Revenue Market Share of Pharmaceutical Grade Safinamide Mesylate by Application (2020-2031)
 Figure 55. Global Pharmaceutical Grade Safinamide Mesylate Price (US$/Ton) by Application (2020-2031)
 Figure 56. Pharmaceutical Grade Safinamide Mesylate Value Chain
 Figure 57. Channels of Distribution (Direct Vs Distribution)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Safinamide Mesylate API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Constrained Peptide Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Super Generic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Memantine Hydrochloride API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Kanamycin Sulfate API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Amikacin Sulfate API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Nikethamide API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Multiple Sclerosis Therapies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharmaceutical Grade Semaglutide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Influenza Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Still s Disease Treatment Market Research Report 2025
Global Treatment Planning Software Market Research Report 2025
Antidepressants Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Insomnia Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharmaceutical Validation Services Market Research Report 2025
Pharmaceutical Grade Famotidine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharmaceutical Grade 2 Cyanopyridine Market Research Report 2025
Global Antidepressant Medication Market Research Report 2025
Global Industrial Explosives Market Research Report 2024
Pharmaceutical Grade Torasemide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions